BIOTRONIK and IMDS Join Forces to Launch Innovative Micro Rx Catheter
BUELACH, Switzerland, Feb. 8, 2024 /PRNewswire/ -- BIOTRONIK is proud to introduce the Micro Rx™ catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions (PCI). This cutting-edge device, exclusively distributed by BIOTRONIK, is manufactured by IMDS (Interventional Medical Device Solutions). Micro Rx catheter marks the fourth IMDS product BIOTRONIK has brought to the U.S., creating a compelling portfolio of devices which includes NHancer Rx, TrapIT, and ReCross catheters.
- This cutting-edge device, exclusively distributed by BIOTRONIK, is manufactured by IMDS (Interventional Medical Device Solutions).
- Micro Rx catheter marks the fourth IMDS product BIOTRONIK has brought to the U.S., creating a compelling portfolio of devices which includes NHancer Rx, TrapIT, and ReCross catheters.
- The Micro Rx catheter is commercially available today in the United States and in March 2024 in Canada.
- "IMDS has invested its expertise and dedication into the development of the Micro Rx catheter, with a specific focus on alleviating challenges in PCI," said Ryan Walters, President at BIOTRONIK USA.